Skip to main content

Table 3 Acute treatment toxicities

From: Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)

Toxicity

No. of patients (%)

CRT group (n = 70)

RT group (n = 70)

Grade 1

Grade 2

Grade 3

Grade 4

Grade 5

Grade 1

Grade 2

Grade 3

Grade 4

Grade 5

Hematological toxicity

Leukopenia

2 (2.9)

11 (15.7)

46 (65.7)

9 (12.9)

31 (44.3)

24 (34.3)

4 (5.7)

0 (0.0)

Neutropenia

7 (10.0)

28 (40.0)

18 (25.7)

9 (12.9)

12 (17.1)

5 (7.1)

1 (1.4)

0 (0.0)

Anemia

52 (74.3)

16 (22.9)

1 (1.4)

0 (0.0)

0 (0.0)

14 (20.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Thrombocytopenia

40 (57.1)

18 (25.7)

4 (5.7)

0 (0.0)

30 (42.9)

5 (7.1)

0 (0.0)

0 (0.0)

Constitutional symptom

Fatigue

43 (61.4)

11 (15.7)

2 (2.9)

14 (20.0)

6 (8.6)

2 (2.9)

GI

Nausea

26 (37.1)

21 (30.0)

5 (7.1)

32 (45.7)

9 (12.9)

5 (7.1)

Vomiting

16 (22.9)

6 (8.6)

1 (1.4)

0 (0.0)

0 (0.0)

6 (8.6)

5 (7.1)

1 (1.4)

0 (0.0)

0 (0.0)

Radiation induced

Dermatitis

23 (32.9)

5 (7.1)

0 (0)

0 (0)

0 (0)

5 (7.1)

1 (1.4)

0 (0.0)

0 (0.0)

0 (0.0)

Esophagitis

49 (70.0)

11 (15.7)

1 (1.4)

0 (0.0)

0 (0.0)

39 (55.7)

5 (7.1)

0 (0.0)

0 (0.0)

0 (0.0)

Pneumonitis

36 (51.4)

17 (24.3)

2 (2.9)

0 (0.0)

2 (2.9)

27 (38.6)

13 (18.6)

1 (1.4)

0 (0.0)

0 (0.0)

  1. Acute AE were defined as occurred during or within 6 months after radiotherapy